These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 31124982)
1. Asthma associated with denatonium benzoate in a healthcare worker in Taiwan: A case report. Chen KH; Chung KM; Chung JH; Chen KT Medicine (Baltimore); 2019 May; 98(21):e15818. PubMed ID: 31124982 [TBL] [Abstract][Full Text] [Related]
2. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate. Cosmetic Ingredient Review Expert Panel Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160 [TBL] [Abstract][Full Text] [Related]
3. Contact urticaria and asthma from denatonium benzoate (Bitrex). Björkner B Contact Dermatitis; 1980 Dec; 6(7):466-71. PubMed ID: 7214890 [TBL] [Abstract][Full Text] [Related]
4. Adverse reactions associated with respirator fit testing of healthcare workers in British Columbia, Canada: a review of compensation claim cases. Youakim S Arch Environ Occup Health; 2007; 62(4):197-200. PubMed ID: 18458024 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of omalizumab (Xolair®) in patients with moderate to severe predominately chronic oral steroid dependent asthma in Taiwan: a retrospective, population-based database cohort study. Chen HC; Huang CD; Chang E; Kuo HP BMC Pulm Med; 2016 Jan; 16():3. PubMed ID: 26747278 [TBL] [Abstract][Full Text] [Related]
6. Denatonium benzoate as a deterrent to ingestion of toxic substances: toxicity and efficacy. Hansen SR; Janssen C; Beasley VR Vet Hum Toxicol; 1993 Jun; 35(3):234-6. PubMed ID: 8351798 [TBL] [Abstract][Full Text] [Related]
7. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846 [TBL] [Abstract][Full Text] [Related]
8. Research on the effectiveness of denatonium benzoate as a deterrent to liquid detergent ingestion by children. Berning CK; Griffith JF; Wild JE Fundam Appl Toxicol; 1982; 2(1):44-8. PubMed ID: 7185601 [TBL] [Abstract][Full Text] [Related]
9. Omalizumab for asthma in adults and children. Normansell R; Walker S; Milan SJ; Walters EH; Nair P Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003559. PubMed ID: 24414989 [TBL] [Abstract][Full Text] [Related]
11. [OMALIZUMAB RESCUED A ASTHMA-COPD OVERLAP SYNDROME PATIENT FROM A STATUS ASTHMATICS UNDER THE ICU MANAGEMENT]. Gamo S; Iijima H; Seki Y; Horaguchi R; Suda Y; Shindoh Y Arerugi; 2016 Jul; 65(7):937-41. PubMed ID: 27545060 [TBL] [Abstract][Full Text] [Related]
12. Denatonium benzoate: review of efficacy and safety. Klein-Schwartz W Vet Hum Toxicol; 1991 Dec; 33(6):545-7. PubMed ID: 1808826 [TBL] [Abstract][Full Text] [Related]
13. Asthma control, lung function, symptoms, and corticosteroid sparing after omalizumab initiation in patients with allergic asthma. Pilon D; Kavati A; Ortiz B; Paknis B; Vegesna A; Schiffman B; Zhdanava M; Lefebvre P; Stone B Allergy Asthma Proc; 2018 Mar; 39(2):127-135. PubMed ID: 29208079 [TBL] [Abstract][Full Text] [Related]
14. Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody. Silkoff PE; Romero FA; Gupta N; Townley RG; Milgrom H Pediatrics; 2004 Apr; 113(4):e308-12. PubMed ID: 15060258 [TBL] [Abstract][Full Text] [Related]
15. Application of XOLAIR® (Omalizumab) in adolescent refractory chest tightness variant asthma. Ding B; Li YQ; Lai Y; Lu YM Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5829-5834. PubMed ID: 36066158 [TBL] [Abstract][Full Text] [Related]
16. Omalizumab Is Equally Effective in Persistent Allergic Oral Corticosteroid-Dependent Asthma Caused by Either Seasonal or Perennial Allergens: A Pilot Study. Domingo C; Pomares X; Navarro A; Rudi N; Sogo A; Dávila I; Mirapeix RM Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264494 [TBL] [Abstract][Full Text] [Related]
17. Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation. Norman G; Faria R; Paton F; Llewellyn A; Fox D; Palmer S; Clifton I; Paton J; Woolacott N; McKenna C Health Technol Assess; 2013 Nov; 17(52):1-342. PubMed ID: 24267198 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous sarcoidosis in a patient with severe asthma treated with omalizumab. Yung S; Han D; Lee JK Can Respir J; 2015; 22(6):315-6. PubMed ID: 26401982 [TBL] [Abstract][Full Text] [Related]
19. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366 [TBL] [Abstract][Full Text] [Related]